6-56620052-A-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001723.7(DST):c.3982T>A(p.Tyr1328Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001723.7 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary sensory and autonomic neuropathy type 6Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001723.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DST | NM_001723.7 | MANE Plus Clinical | c.3982T>A | p.Tyr1328Asn | missense | Exon 23 of 24 | NP_001714.1 | ||
| DST | NM_001374736.1 | MANE Select | c.4929+4478T>A | intron | N/A | NP_001361665.1 | |||
| DST | NM_001374734.1 | c.4956+4478T>A | intron | N/A | NP_001361663.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DST | ENST00000370765.11 | TSL:1 MANE Plus Clinical | c.3982T>A | p.Tyr1328Asn | missense | Exon 23 of 24 | ENSP00000359801.6 | ||
| DST | ENST00000680361.1 | MANE Select | c.4929+4478T>A | intron | N/A | ENSP00000505098.1 | |||
| DST | ENST00000244364.10 | TSL:1 | c.3318+4478T>A | intron | N/A | ENSP00000244364.6 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152052Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250904 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461664Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727150 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74266 show subpopulations
ClinVar
Submissions by phenotype
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with DST-related disease. This variant is present in population databases (rs771206867, ExAC 0.01%). This sequence change replaces tyrosine with asparagine at codon 1328 of the DST protein (p.Tyr1328Asn). The tyrosine residue is weakly conserved and there is a large physicochemical difference between tyrosine and asparagine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at